BIOLOGICAL · Unmapped registry intervention
IDO peptide vaccination
Find medicine records ·
Find other trials using this name
Clinical trial
IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.
NCT01219348
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedIDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
NSCLCverified · MONDO: non-small cell lung carcinoma
Lung Cancerverified · MONDO: lung cancer
Interventions
IDO peptide vaccinationBIOLOGICAL
Sponsors & collaborators
Inge Marie Svanelead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01219348 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.